Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/24810
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders |
Autor: | Luna Medina, Rosario de CSIC; Cortés-Canteli, Marta CSIC ORCID; Sánchez-Galiano, Susana CSIC; Morales-García, José A. CSIC ORCID; Martínez Gil, Ana CSIC ORCID ; Santos, Ángel; Pérez Castillo, Ana CSIC ORCID | Palabras clave: | Excitotoxicity Neurodegenerative diseases Neuroinflammation Neuroprotection Peroxisome proliferator-activated receptor Thiadiazolidinones |
Fecha de publicación: | 23-may-2007 | Editor: | Society for Neuroscience | Citación: | Journal of Neuroscience 27(21): 5766-5776 (2007) | Resumen: | Inflammation and neurodegeneration coexist in many acute damage and chronic CNS disorders (e.g., stroke, Alzheimer's disease, Parkinson's disease). A well characterized animal model of brain damage involves administration of kainic acid, which causes limbic seizure activity and subsequent neuronal death, especially in the CA1 and CA3 pyramidal cells and interneurons in the hilus of the hippocampus. Our previous work demonstrated a potent anti-inflammatory and neuroprotective effect of two thiadiazolidinones compounds, NP00111 (2,4-dibenzyl-[1,2,4]thiadiazolidine-3,5-dione) and NP01138 (2-ethyl-4-phenyl-[1,2,4]thiadiazolidine-3,5-dione), in primary cultures of cortical neurons, astrocytes, and microglia. Here, we show that injection of NP031112, a more potent thiadiazolidinone derivative, into the rat hippocampus dramatically reduces kainic acid-induced inflammation, as measured by edema formation using T2-weighted magnetic resonance imaging and glial activation and has a neuroprotective effect in the damaged areas of the hippocampus. Last, NP031112-induced neuroprotection, both in vitro and in vivo, was substantially attenuated by cotreatment with GW9662 (2-chloro-5-nitrobenzanilide), a known antagonist of the nuclear receptor peroxisome proliferator-activated receptor gamma, suggesting that the effects of NP031112 can be mediated through activation of this receptor. As such, these findings identify NP031112 as a potential therapeutic agent for the treatment of neurodegenerative disorders. | Descripción: | 11 pages, 6 figures. | Versión del editor: | http://dx.doi.org/10.1523/JNEUROSCI.1004-07.2007 | URI: | http://hdl.handle.net/10261/24810 | DOI: | 10.1523/JNEUROSCI.1004-07.2007 | ISSN: | 0270-6474 |
Aparece en las colecciones: | (IIBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
NP031112.pdf | 952,34 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
40
checked on 19-mar-2024
SCOPUSTM
Citations
107
checked on 15-abr-2024
WEB OF SCIENCETM
Citations
99
checked on 24-feb-2024
Page view(s)
410
checked on 19-abr-2024
Download(s)
305
checked on 19-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.